In-vitro dissolution and drug delivery
Medway School of Pharmacy associated with Colorcon Inc.
Development of an in-vitro testing method to be used for investigation of parandial effects on hydrophilic hypromellose matrix tablets
Dr Ali Nokhodchi (Universities of Kent and Greenwich) & Dr Ali R. Rajabi-Siahboomi (Colorcon Inc.)
The Medway School of Pharmacy is inviting applications for a distinguished three-year EPSRC Industrial CASE Ph.D. studentship commencing in September 2008. The studentship is open to UK. EU nationals would be eligible if they have been in UK for at least 3 years. Overseas students are eligible for this post if the student can demonstrate that they have been ordinarily resident in the UK for the previous three years (i.e. that they have had an unrestricted leave to stay and that their stay in the UK has not been restricted by a student and/or other visa, or condition). This is due to the nature of the funding and will attract an annual stipend of £12608.
It is documented that the extended release of drug from hydrophilic matrix tablets may be affected by co-administration of food. Changes of the tablet erosion have been reported as an important component for this effect. The aim of the Ph.D. project will be to identify the postprandial factors responsible for changes in tablet erosion and to develop predictive in-vitro test methods.
Candidates with an interest in drug delivery and pharmaceutical sciences are invited to apply. You will have obtained a Masters or B.Sc. (first or upper second class) or equivalent in pharmacy, chemical engineering, pharmaceutical sciences or joint disciplines.
Applications, including a covering letter detailing research interests and aspirations, a detailed CV including names and contact details of two referees should be sent to Dr Ali Nokhodchi (E-mail:a.nokhodchi@kent.ac.uk or a.nokhodchi@gre.ac.uk Tel: 01634883846).
Closing date for application is 22 August 2008.
